
Victor Ho Fun LeeThe University of Hong Kong | HKU · Department of Clinical Oncology
Victor Ho Fun Lee
MBBS, MD, FRCR, FHKCR, FHKAM
About
379
Publications
34,868
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
5,619
Citations
Citations since 2017
Introduction
Dr. Victor Lee is currently Clinical Associate Professor of the Department of Clinical Oncology, The University of Hong Kong. He graduated in the University of Hong Kong in 2002. After internship, he received post-graduate residency training in clinical oncology in Tuen Mun Hospital, Hong Kong. He joined the Department of Clinical Oncology in 2008. He obtained his fellowship in Royal College of Radiologists in Clinical Oncology in 2010. Afterwards, he received further specialist training in interstitial brachytherapy for head and neck cancers and sarcoma in Institut Gustave Roussy in Paris, France and novel radiation techniques like stereotactic radiosurgery and stereotactic ablative radiotherapy in Stanford University USA. In 2013, he received further training on stereotactic body radiati
Additional affiliations
June 2017 - present
May 2008 - May 2017
May 2008 - present
Publications
Publications (379)
Background
Sinonasal neoplasms, whether benign and malignant, pose a significant challenge to clinicians and represents a model area for multidisciplinary collaboration in order to optimize patient care. The International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors (ICSNT) aims to summarize the best available evidence and present...
Recently, deep learning has been demonstrated to be feasible in eliminating the use of gadolinium-based contrast agents (GBCAs) through synthesizing gadolinium-free contrast-enhanced MRI (GFCE-MRI) from contrast-free MRI sequences, pro-viding the community with an alternative to get rid of GBCAs-associated safety issues in patients. Nevertheless, g...
Purpose:
Although several agents targeting epidermal growth factor receptor (EGFR) exon 20 insertions (ex20ins) have recently been approved by the US Food and Drug Administration, toxicities related to the inhibition of wild-type (WT) EGFR are common with these agents and affect overall tolerability. Zipalertinib (CLN-081, TAS6417) is an oral EGFR...
Purpose:
Although systemic treatment is the mainstay for advanced hepatocellular carcinoma (HCC), numerous studies have highlighted the added value of local treatment. This study aimed to investigate the clinical efficacy of liver-directed combined radiotherapy (LD combined RT) compared with that of sorafenib, a recommended treatment until recentl...
Purpose:
This study aimed to discover intra-tumor heterogeneity signature and validate its predictive value for adjuvant chemotherapy (ACT) following concurrent chemoradiotherapy (CCRT) in locoregionally advanced nasopharyngeal carcinoma (LA-NPC).
Materials and methods:
397 LA-NPC patients were retrospectively enrolled. Pre-treatment contrast-en...
Background:
The meta-analysis of chemotherapy for nasopharynx carcinoma (MAC-NPC) collaborative group previously showed that the addition of adjuvant chemotherapy to concomitant chemoradiotherapy had the highest survival benefit of the studied treatment regimens in nasopharyngeal carcinoma. Due to the publication of new trials on induction chemoth...
e15161
Background: CD8 ⁺ T lymphocytes are believed to be the major anti-tumor immune subsets. Consequently, most cancer immunotherapeutic approaches seek to amplify cytotoxic T lymphocytes specific to malignant cells. A recently identified subpopulation of memory CD8 ⁺ T cells, named tissue-resident memory T (Trm) cells, persists in non-lymphoid t...
6035
Background: Epstein-Barr Virus (EBV) is associated with a diverse collection of malignancies, including nasopharyngeal carcinoma (NPC). One viral-encoded protein, EBNA1, is consistently expressed in all known EBV-associated malignancies and is critical for the replication and maintenance of the EBV genome in latently infected cells. VK-2019 is...
e14622
Background: Anti-programmed cell death protein-ligand 1 (PD-L1) monotherapy has not shown promising anti-tumor effects in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC) in first-line settings. Consequently, second-generation checkpoint inhibitors via targeting multiple pathways are urgently needed. Bintrafusp alfa (also known as M78...
Background:
Next-generation sequencing comprehensive genomic panels (NGS CGPs) have enabled the delivery of tailor-made therapeutic approaches to improve survival outcomes in patients with cancer. Within the China Greater Bay Area (GBA), territorial differences in clinical practices and health care systems and strengthening collaboration warrant a...
Background and purpose:
Physiological changes in tumour occur much earlier than morphological changes. They can potentially be used as biomarkers for therapeutic response prediction. This study aimed to investigate the optimal time for early therapeutic response prediction with multi-parametric magnetic resonance imaging (MRI) in patients with nas...
Lung adenocarcinoma is the most common type of lung cancer. Known risk variants explain only a small fraction of lung adenocarcinoma heritability. Here, we conducted a two-stage genome-wide association study of lung adenocarcinoma of East Asian ancestry (21,658 cases and 150,676 controls; 54.5% never-smokers) and identified 12 novel susceptibility...
Nasopharyngeal carcinoma (NPC), with the highest incidence and prevalence in Southern China including Hong Kong, originates from the nasopharyngeal epithelium and frequently metastasises to cervical lymph nodes and distal organs such as liver. Radiation therapy with/without concurrent chemoradiation is the most common first-line treatment. Although...
Introduction:
The immunosuppressive tumor microenvironment is a major barrier for chemotherapy. Different chemosensitization approaches to reinstate immunological surveillance for cancers that are immune quiescent at the outset, have thus been devised. Cancer-specific ENOX2 expression is correlated with abnormal cell growth and has been proposed a...
Objective:
We sought to identify predictors of delayed viral clearance in cancer patients with asymptomatic COVID-19 when the SARS-CoV-2 omicron variants prevailed in Hong Kong.
Methods:
All cancer patients attending radiation therapy for head and neck malignancies or systemic anti-cancer therapy saved their deep-throat saliva or nasopharyngeal...
Purpose:
To develop a respiratory-correlated four-dimensional imaging technique based on magnetic resonance fingerprinting (MRF), i.e., RC-4DMRF, for liver tumor motion management in radiotherapy.
Methods:
Thirteen liver cancer patients were prospectively enrolled in this study. k-space MRF signals of the liver were acquired during free-breathin...
Background:
The integration of next-generation sequencing (NGS) comprehensive gene profiling (CGP) into clinical practice is playing an increasingly important role in oncology. Therefore, the HKU-HKSH Multi-disciplinary Molecular Tumour Board (MTB) was established to advance precision oncology in Hong Kong. A multicenter retrospective study invest...
The study aimed to develop liquid biopsy assays for early hepatocellular carcinoma (HCC) diagnosis and prognosis. The study is the first to integrate circulating miRNAs, AST, ALT, AFP, and machine learning for predicting DFS in early HCC patients undergoing hepatectomy.
Study objectives:
To examine the trajectories of sleep disturbance in cancer survivors during the first two years post-treatment and to investigate whether psychological, cognitive and physical factors differentiate trajectories.
Methods:
A total of 623 Chinese cancer survivors of diverse cancer types participated in a 2-year-long prospective st...
Introduction:
Lorlatinib is a potent, third-generation inhibitor of ALK. In the planned interim analysis of the ongoing, phase 3, randomized, global CROWN trial (NCT03052608), lorlatinib resulted in significantly longer progression-free survival than crizotinib in patients with previously untreated, advanced, ALK-positive NSCLC. Here, we present a...
Purpose: This study aims to develop liquid biopsy assays for early HCC diagnosis and prognosis.
Methods: Twenty-three microRNAs were first consolidated as a panel (HCCseek-23 panel) based on their reported functions in HCC development. Serum samples were collected from 103 early-stage HCC patients before and after hepatectomy. Quantitative PCR and...
565
Background: While systemic treatment is the mainstay for advanced hepatocellular carcinoma (HCC), numerous studies have highlighted the added value of local treatment. This study aimed to investigate the clinical efficacy of liver-directed combined radiotherapy (LD-CRT) compared to sorafenib, a recommended treatment until recently in locally ad...
Background and purpose:
To investigate the radiomic feature (RF) repeatability via perturbation and its impact on cross-institutional prognostic model generalizability in Nasopharyngeal Carcinoma (NPC) patients.
Materials and methods:
286 and 183 NPC patients from two institutions were included for model training and validation. Perturbations wi...
Background and aims:
Deregulation of adenosine-to-inosine (A-to-I) editing by adenosine deaminase acting on RNA 1 (ADAR1) leads to tumor-specific transcriptome diversity with prognostic values for hepatocellular carcinoma (HCC). However, ADAR1 editase-dependent mechanisms governing liver cancer stem cell (LCSC) generation and maintenance have rema...
This study aims to investigate the feasibility of improving the prognosis stratification of the N staging system of Nasopharyngeal Carcinoma (NPC) from quantitative spatial characterizations of metastatic lymph node (LN) for NPC in a multi-institutional setting. A total of 194 and 284 NPC patients were included from two local hospitals as the disco...
Hepatocellular carcinoma (HCC) is a major public health burden in Hong Kong, and chronic hepatitis B is the most common HCC etiology in our region. With the high case load, extensive local expertise on HCC has been accumulated. This article summarized local guidelines and real-life practice on HCC management in Hong Kong. For HCC surveillance, live...
Background
In the global REACH-2 study, ramucirumab significantly improved overall survival (OS) compared with placebo in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP). REACH-2 China study aimed to evaluate the efficacy and safety of ramucirumab in Chinese patients with advanced HCC (NCT02435433).
Metho...
Background
Epstein-Barr virus (EBV) latent infection is associated with genome-wide epigenomic changes in several malignancies, but its role in epigenetic dysregulation remains unclear in nasopharyngeal carcinoma (NPC).
Methods
To investigate EBV-associated epigenetic dysregulation, we performed a multi-omics study by integrating whole-genome bisu...
The effects of the COVID-19 pandemic continue to constrain health-care staff and resources worldwide, despite the availability of effective vaccines. Aerosol-generating procedures such as endoscopy, a common investigation tool for nasopharyngeal carcinoma, are recognised as a likely cause of SARS-CoV-2 spread in hospitals. Plasma Epstein-Barr virus...
Background:
Pembrolizumab previously demonstrated robust antitumor activity and manageable safety in a phase Ib study of patients with heavily pretreated, PD-L1-positive, recurrent or metastatic nasopharyngeal carcinoma (NPC). The phase III KEYNOTE-122 study was conducted to further evaluate pembrolizumab versus chemotherapy in patients with plati...
Radiotherapy with electrons is commonly applied to the tumor bed after whole-breast radiotherapy following breast conservation surgery for breast cancer patients. However, the radiation dose to adjacent organs-at-risk (OARs) and conformity of planning target volume (PTV) cannot be optimized. In this study, we examine the feasibility of using modula...
Wen Li Saikit Lam Tian Li- [...]
Jing Cai
p>In this study, we aimed at investigating generalizability of GFCE-MRI model using data from seven institutions by manipulating heterogeneity of training MRI data under two popular normalization approaches. A multimodality-guided synergistic neural network (MMgSN-Net) was applied to map from T1-weighted and T2-weighted MRI to contrast-enhanced MRI...
Background
Using high robust radiomic features in modeling is recommended, yet its impact on radiomic model is unclear. This study evaluated the radiomic model’s robustness and generalizability after screening out low-robust features before radiomic modeling. The results were validated with four datasets and two clinically relevant tasks.
Material...
Wen Li Saikit Lam Tian Li- [...]
Jing Cai
p>In this study, we aimed at investigating generalizability of GFCE-MRI model using data from seven institutions by manipulating heterogeneity of training MRI data under two popular normalization approaches. A multimodality-guided synergistic neural network (MMgSN-Net) was applied to map from T1-weighted and T2-weighted MRI to contrast-enhanced MRI...
Wen Li Saikit Lam Tian Li- [...]
Jing Cai
p>In this study, we aimed at investigating generalizability of GFCE-MRI model using data from seven institutions by manipulating heterogeneity of training MRI data under two popular normalization approaches. A multimodality-guided synergistic neural network (MMgSN-Net) was applied to map from T1-weighted and T2-weighted MRI to contrast-enhanced MRI...
We attempted to investigate the Radiomic feature (RF) repeatability and its agreements across imaging modalities and head-and-neck cancer (HNC) subtypes via image perturbations. Contrast-enhanced computed tomography (CECT), CET1-weight, T2-weight magnetic resonance images of 231 nasopharyngeal carcinoma (NPC) patients, and CECT images of 399 oropha...
Wen Li Saikit Lam Tian Li- [...]
Jing Cai
The purpose of this study is to investigate the model generalizability using multi-institutional data for virtual contrast-enhanced MRI (VCE-MRI) synthesis. This study presented a retrospective analysis of contrast-free T1-weighted (T1w), T2-weighted (T2w), and gadolinium-based contrast-enhanced T1w MRI (CE-MRI) images of 231 NPC patients enrolled...
Background/purpose:
The Asian Liver Radiation Therapy Study Group has formed a large and detailed multinational database of outcomes following stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC). Here, we explored the potential impact of HCC etiology on SBRT efficacy. Tumor control probability (TCP) models were establishe...
(1) Background: Randomized controlled trials (RCTs) have explored various primary treatments for individuals diagnosed as having later-stage epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer. Nevertheless, the extent to which such treatments are efficacious, particularly with regard to overall survival (OS) rates of patient...
(1) Background: SMARCB1 (INI-1)-deficient sinonasal carcinoma is a rare sinonasal malignancy; since its discovery and description in 2014, less than 200 cases have been identified. It is almost impossible to perform randomized-controlled trials on novel therapy to improve treatment outcomes in view of its rarity. We performed a systematic review of...
Background: Hepatocellular carcinoma (HCC) is one of the most common and most difficult to cure malignancies worldwide. Identifying new effective therapeutic targets is of great significance for the management of HCC. Cumulative evidence suggests cancer stem cells (CSCs) are key drivers of tumor growth and heterogeneity. Post-transcriptional RNA ed...
Background: NPC is particularly common in Southern China and Southeast Asia. The standard treatment for NPC is radiotherapy with or without adjuvant chemotherapy. Despite the high 5-year overall survival rate (85.6%) in early-stage patients, 15% to 20% of the patients still experience recurrence or metastasis. The development of new targeted therap...
9007
Background: EGFR ins20-mutant NSCLC has historically been challenging to treat. While new agents targeting EGFR ins20 have recently been approved, adverse events (AEs), particularly wild type (WT) EGFR-related AEs are common. CLN-081 is a novel EGFR tyrosine kinase inhibitor (TKI) with broad activity against EGFR mutations, including ins20, an...
e21064
Background: First-line epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) and their biologically synergistic combinations with other treatments for patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC) as first-line treatment for EGFR-mutant NSCLC have recently gained considerable attention, in particu...
e16176
Background: Dual-tracer positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose and 11C-acetate is increasingly used in the management of hepatocellular carcinoma (HCC). However, considering the high cost of dual-tracer PET/CT, there is a need to assess its value by considering both the efficacy and cost. Method...
e14534
Background: Nasopharyngeal carcinoma (NPC) is endemic in Southern China and is well-known to be heavily infiltrated by lymphocytes and constitute a unique but poorly defined tumor microenvironment. We aimed at delineating and defining the contribution of idronoxil (IDX), a synthetic flavonoid derivative, in restoring sensitivity to apoptosis...
Background
The World Health Organization has defined a list of adverse events of special interest (AESI) for safety surveillance of vaccines. AESI have not been adequately assessed following COVID-19 vaccination in patients with cancer contributing to vaccine hesitancy in this population. We aimed to evaluate the association between BNT162b2 and Co...
Several B-cell subsets with distinct functions and polarized cytokine profiles that extend beyond antibody production have been reported in different cancers. Here we have demonstrated that proliferating B cells were predominantly found in the peritumoral region of esophageal squamous cell carcinoma (ESCC). These B cells were enriched in tumor nest...
(1) Background: We performed a meta-analysis to examine whether combined epidermal growth factor tyrosine kinase inhibitor (EGFR-TKI) and immune checkpoint inhibitor (ICI) increases treatment-related adverse events (trAEs) in advanced non-small cell lung cancer (NSCLC). (2) Methods: Articles from MEDLINE, EMBASE, and Cochrane databases were searche...
Myelodysplastic syndrome (MDS) is a clonal myeloid neoplasm characterized by ineffective hematopoiesis, cytopenia, dysplasia, and clonal instability, leading to leukemic transformation. Hypomethylating agents are the mainstay of treatment in higher-risk MDS. However, treatment resistance and disease transformation into acute myeloid leukemia (AML)...
(1) Background: NPC patients with de novo distant metastasis appears to be a heterogeneous group who demonstrate a wide range of survival, as suggested by growing evidence. Nevertheless, the current 8th edition of TNM staging (TNM-8) grouping all these patients into the M1 category is not able to identify their survival differences. We sought to id...
Introduction
Randomized-controlled trials (RCTs) have investigated different first-line treatments for patients with advanced epidermal growth factor receptor (EGFR) mutated non-small-cell lung cancer. However, their efficacy, in particular, the long-term overall survival (OS) benefit in Asian patients with L858R mutation remains unclear.
Methods...
Objectives
Working-age cancer patients face barriers to resuming work after treatment completion. Those resuming work contend with reduced productivity arising from persisting residual symptoms. Existing studies of return to work (RTW) after cancer diagnosis were done predominantly in Western countries. Given that employment and RTW in cancer survi...
Background:
We conducted this study to evaluate if a reduced cumulative dose of induction and concurrent cisplatin conferred similar favorable outcomes when compared to trial NPC-0501.
Methods:
Newly diagnosed nasopharyngeal carcinoma (NPC) with stage III-IVA were prospectively recruited from January 2015 to September 2019. Induction chemotherap...
Endoscopic endonasal surgery has been demonstrated to be effective in the treatment of selected cases of sinonasal cancers. However, in cases of locally advanced neoplasms, as well as recurrences, the most appropriate approach is still debated. The present review aims to summarize the current state of knowledge on the utility of open approaches to...
Introduction
Decision-making in diagnosis and management of stage III NSCLC remains complex due to disease heterogeneity and diverse treatment options, and often warrants multidisciplinary team discussion. Specifically, selection of patients for multimodality approaches involving surgical resection presents notable challenges, due to heterogeneity...
Purpose
Tumor delineation plays a critical role in radiotherapy for hepatocellular carcinoma (HCC) patients. The incorporation of MRI might improve the ability to correctly identify tumor boundaries and delineation consistency. In this study, we evaluated a novel Multisource Adaptive MRI Fusion (MAMF) method in HCC patients for tumor delineation....
Myelodysplastic syndrome (MDS) is a clonal myeloid neoplasm characterized by ineffective hematopoiesis, cytopenia, dysplasia and clonal instability leading to leukemic transformation. Hypomethylating agents are the mainstay of treatment in higher-risk MDS. However, treatment resistance and disease transformation into acute myeloid leukemia (AML) is...
Significant lymph node shrinkage is common in patients with nasopharyngeal carcinoma (NPC) throughout radiotherapy (RT) treatment, causing ill-fitted thermoplastic masks (IfTMs). To deal with this, an ad hoc adaptive radiotherapy (ART) may be required to ensure accurate and safe radiation delivery and to maintain treatment efficacy. Presently, the...
Background:
Most available 4D-MRI techniques are limited by insufficient image quality and long acquisition times or require specially designed sequences or hardware that are not available in the clinic. These limitations have greatly hindered the clinical implementation of 4D-MRI.
Purpose:
This study aims to develop a fast ultra-quality (UQ) 4D...
Purpose
To investigate the role of different multi-organ omics-based prediction models for pre-treatment prediction of Adaptive Radiotherapy (ART) eligibility in patients with nasopharyngeal carcinoma (NPC).
Methods and Materials
Pre-treatment contrast-enhanced computed tomographic and magnetic resonance images, radiotherapy dose and contour data...
Introduction:
Nasopharyngeal carcinoma (NPC) is endemic to Eastern and South-Eastern Asia, and, in 2020, 77% of global cases were diagnosed in these regions. Apart from its distinct epidemiology, the natural behavior, treatment, and prognosis are different from other head and neck cancers. With the growing trend of artificial intelligence (AI), es...
Background
Afatinib has been shown as a suitable option for the treatment of epidermal growth factor receptor mutation-positive (EGFRm+) non-small-cell lung cancer (NSCLC) in randomized controlled trials. However, patients treated in real-world clinical practice, including elderly patients, and those with brain metastases or poor Eastern Cooperativ...
Lung cancer is a major cause of cancer deaths worldwide, and has a very low survival rate. Non-small cell lung cancer (NSCLC) is the largest subset of lung cancers, which accounts for about 85% of all cases. It has been well established that mutation in epidermal growth factor receptor (EGFR) can lead to lung cancer. EGFR Tyrosine Kinase Inhibitors...